Enlarge / Heather Bresch, chief executive officer of Mylan.Getty | Bloomberg reader comments 5 Share this story In a settlement announced Friday, Mylan, Inc., the maker of EpiPens, will shell out $465 million to the Department of Justice and other federal agencies to brush aside any questions about its Medicaid rebates. Further ReadingFeds go after...